TGTX icon

TG Therapeutics

233 hedge funds and large institutions have $1.57B invested in TG Therapeutics in 2023 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 78 increasing their positions, 70 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

0.63% more ownership

Funds ownership: 60.05%60.68% (+0.63%)

0% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 39

1% less funds holding

Funds holding: 235233 (-2)

Holders
233
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$85.5M
Puts
$63.8M
Net Calls
Net Calls Change

Top Buyers

1 +$69.1M
2 +$43.8M
3 +$27.6M
4
Morgan Stanley
Morgan Stanley
New York
+$18.8M
5
Marshall Wace
Marshall Wace
United Kingdom
+$17.4M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$960K
102
$960K
103
$939K
104
$926K
105
$872K
106
$840K
107
$834K
108
$798K
109
$738K
110
$722K
111
$715K
112
$707K
113
$685K
114
$674K
115
$669K
116
$669K
117
$660K
118
$659K
119
$655K
120
$621K
121
$582K
122
$576K
123
$567K
124
$566K
125
$561K